NYSE$CTRE

CareTrust REIT Inc · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Reported operating results for the quarter ended March 31, 2020.

CareTrust REIT reported a net income of $19.3 million, normalized FFO of $32.3 million, and normalized FAD of $33.7 million for the quarter ended March 31, 2020. The company collected 99.3% of contract rents in April and expects a similar result in May. They also increased the quarterly dividend from $0.225 to $0.25 per common share.

  • Net income was reported at $19.3 million, or $0.20 per diluted share.
  • Normalized FFO was $32.3 million, or $0.34 per diluted share.
  • Normalized FAD was $33.7 million, or $0.35 per diluted share.
  • Net debt-to-normalized EBITDA ratio was 3.5x, and net debt-to-enterprise value was 28% at quarter-end.

Headline financials

Total Revenue

$44.3M

Previous: $39.7M+11.8%
EPS (adj)

$0.34

Previous: $0.32+6.3%
Net Debt to Annualized Normalized Run Rate EBITDA

3.5

No prior period
Quarterly dividend per common share

$0.25

Previous: $0.23+11.1%
Capital Expenditures

-$29.3M

Previous: -$1.81M-1519.6%
Free Cash Flow

-$9.93M

Previous: $14.2M-169.7%
Net Income

$19.3M

Previous: $16.1M+20.4%
Operating Income

$26.6M

Previous: $15.3M+73.2%
Gross Profit

$43.8M

Previous: $39M+12.4%
Cash & Equivalents

$23.9M

Previous: $214M-88.8%
Total Assets

$1.53B

Previous: $1.52B+0.5%

Revenue & EPS history

CareTrust REIT · Revenue · Quarterly

$44.3M

Q1 2020+11.8%vs Q1 2019
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Forward guidance

CareTrust REIT acknowledged the uncertainty facing financial markets and the healthcare industry during the COVID-19 pandemic and stated that any annual earnings guidance offered at this time would seem speculative at best. With the support providers are receiving, it appears possible that the previously issued guidance could be achieved, although the unknowns still loom large and will continue to do so for some time to come. They are accordingly neither updating nor withdrawing their prior guidance at this time, but are adding the caveat that changes in economic and other factors related to the COVID-19 pandemic and the government’s responses thereto could alter their outlook in the future.

Tailwinds

  • Supplemental payments to healthcare providers from the CARES Act
  • Medicare advance payment program
  • Suspension of sequestration
  • Paycheck Protection Program
  • Various state Medicaid rate increases, as well as the waiver of the three-day qualifying stay rule

Headwinds

  • Uncertainty facing financial markets
  • Uncertainty in the healthcare industry during the COVID-19 pandemic
  • Costs are up
  • Occupancy is down
  • Changes in economic and other factors related to the COVID-19 pandemic and the government’s responses thereto could alter their outlook in the future

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+0.5%

Avg return

Earnings day

+1.5%

Avg return

5 days after

+3.1%

Avg return

30 days after

58%

30 / 52 earnings

Positive

+11.7%

Q1 2020

Best reaction

-9.4%

Q4 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.7%+7.5%-3.9%
Q4 2025-0.3%+0.0%-0.3%
Q3 2025-1.2%+1.4%+4.7%
Q1 2025+0.8%+1.4%+1.5%
Q4 2024+3.7%+1.5%+11.1%
Q3 2024+4.8%+3.4%-4.5%
Q2 2024+1.6%+1.6%+10.8%
Q1 2024+0.2%-0.2%+2.6%
Q4 2023+9.0%+9.3%+12.7%
Q3 2023+3.5%+7.0%+5.2%
Q2 2023+0.3%+0.8%+0.3%
Q1 2023+1.7%+1.5%+0.6%
Q4 2022-0.6%+0.3%-6.6%
Q3 2022-1.9%+3.4%+5.2%
Q2 2022-1.2%+2.3%-0.6%
Q1 2022-0.5%-4.8%+5.6%
Q4 2021-6.3%-6.9%-3.7%
Q3 2021+0.1%-1.6%+7.3%
Q2 2021+2.7%-1.1%-2.0%
Q1 2021+2.9%+1.6%+3.4%
Q4 2020+0.1%-0.7%+3.0%
Q3 2020+0.9%+9.1%+16.3%
Q2 2020+4.0%+5.1%+7.7%
Q1 2020+11.7%+8.5%+27.5%
Q4 2019+2.2%+0.7%-44.8%
Q3 2019-8.6%-12.2%-4.7%
Q2 2019-0.7%-0.5%+6.4%
Q1 2019-1.5%+0.6%-1.9%
Q4 2018+1.4%+2.6%+9.2%
Q3 2018+8.1%+10.5%+12.9%
Q2 2018+0.7%+5.6%+9.1%
Q1 2018+7.6%+7.0%+18.1%
Q4 2017-9.4%-9.6%-8.3%
Q3 2017-4.4%-4.7%-9.8%
Q2 2017+0.5%-0.7%+6.3%
Q1 2017-3.0%-0.8%+8.0%
Q4 2016+2.3%+2.0%-1.5%
Q3 2016-3.6%+0.6%+6.7%
Q2 2016+4.4%+5.9%+11.2%
Q1 2016-0.7%
Q4 2015+2.4%
Q3 2015-5.4%
Q2 2015-8.4%
Q1 2014+7.6%
Q1 2015+7.6%
Q4 2014-2.6%
Q1 2013+1.6%
Q3 2014+7.5%
Q3 2013+7.5%
Q2 2014-6.8%
Q4 2013-6.8%
Q2 2013-6.8%
Q4 2012
Q3 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro